Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT scans for diagnosing ovarian cancer recurrence

European Journal of Radiology

Volumn 81, Issue 11, 2012, Pages 3557-3562

  Kitajima, Kazuhiro ^a   Ueno, Yoshiko ^a   Suzuki, Kayo ^b   Kita, Masato ^c   Ebina, Yasuhiko ^a   Yamada, Hideto ^a   Senda, Michio ^b   Maeda, Tetsuo ^a   Sugimura, Kazuro ^b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

Author keywords

Contrast enhanced CT; Non enhanced CT; Ovarian cancer; PET CT; Recurrence

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOPAMIDOL;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; RADIATION DOSE; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROGNOSIS; RADIATION DOSAGE; RADIATION PROTECTION; RADIOPHARMACEUTICALS; TREATMENT OUTCOME;

EID: 84866980028     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2012.03.020     Document Type: Article

References (20)

1. R.E. Bristow, L.R. Duska, and N.C. Lambrou A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography Cancer 89 2000 1532 1540
2. K. Kitajima, K. Murakami, and E. Yamasaki Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT European Journal of Nuclear Medicine and Molecular Imaging 35 2008 1439 1448
3. E.A. Hauth, G. Antoch, and J. Stattaus Evaluation of integrated whole-body PET/CT in the detection of recurrent ovarian cancer European Journal of Radiology 56 2005 263 268
4. 18FFDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings European Journal of Nuclear Medicine and Molecular Imaging 34 2007 480 486
5. G. Mangili, M. Picchio, and S. Sironi Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer European Journal of Nuclear Medicine and Molecular Imaging 34 2007 658 666
6. M.M. Thrall, J.A. DeLoia, H. Gallion, and N. Avril Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer Gynecologic Oncology 105 2007 17 22
7. S. Sebastian, S.I. Lee, and N.S. Horowitz PET-CT vs CT alone in ovarian cancer recurrence Abdominal Imaging 33 2008 112 118
8. M.J. Fulham, J. Carter, A. Baldey, R.J. Hicks, J.E. Ramshaw, and M. Gibson The impact of PET/CT in suspected recurrent ovarian cancer: a prospective multi-centre study as part of the Australian PET Data collection project Gynecologic Oncology 112 2009 462 468
9. S. Makhija, N. Howden, R. Edwards, J. Kelley, D.W. Townsend, and C.C. Meltzer Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review Gynecologic Oncology 85 2002 53 58
10. R.E. Bristow, M.G. Del Carmen, and H.K. Pannu Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT Gynecologic Oncology 90 2003 519 528
11. S. Sironi, C. Messa, and G. Mangili Integrated FDG-PET/CT in patients with persistent ovarian cancer: Correlation with histologic findings Radiology 233 2004 433 440
12. R.E. Bristow, R.L. Giuntoli II, H.K. Pannu, R.D. Schulick, E.K. Fishman, and R.L. Wahl Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes Gynecologic Oncology 99 2005 294 300
13. R.E. Coleman, D. Delbeke, and M.J. Guiberteau American College of Radiology; Society of Nuclear Medicine; Society of Computed Body Tomography and Magnetic Resonance, Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance Journal of Nuclear Medicine 46 2005 1225 1239
14. 18F-FDG PET/CT Journal of Nuclear Medicine 45 2004 56 65
15. B. Rodriguez-Vigil, N. Gomez-Leon, and I. Pinilla PET/CT in Lymphoma: prospective study of enhanced full-dose PET/CT versus unenhanced low-dose PET/CT Journal of Nuclear Medicine 47 2006 1643 1648
16. A.C. Pfannenberg, P. Aschoff, and K. Brechtel Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancer European Journal of Nuclear Medicine and Molecular Imaging 34 2007 36 44
17. 18F-FDG PET/CT: 1-stop-shop imaging for assessing the respectability of pancreatic cancer Journal of Nuclear Medicine 49 2008 1408 1413
18. K. Kitajima, K. Suzuki, and Y. Nakamoto Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT studies for the diagnosis of uterine cancer recurrence European Journal of Nuclear Medicine and Molecular Imaging 37 2009 1490 1498
19. 18F-FDG PET/CT the diagnostic tool of choice Journal of Nuclear Medicine 49 2008 354 361
20. O. Mawlawi, J.J. Erasmus, and R.F. Munden Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation AJR. American Journal of Roentgenology 186 2006 308 319